1. Introduction {#sec1}
===============

In recent times, diseases caused by foodborne pathogens have been the object of an increasing number of studies \[[@B1]\]. This is owing to the rates of morbidity and mortality that can be achieved by such diseases and the impact that they have in both public health and social economic costs. Among the different bacteria responsible for foodborne diseases,*Salmonella enterica* represents one of the leading causes of such infections with*S.* Enteritidis and*S.* Typhimurium being the most common serovars isolated from humans in Europe and the USA \[[@B2]\]. However, while in Europe*S.* Enteritidis still remains the predominant serovar from clinical cases, in Italy it is the serovar*S.* Typhimurium which is prevalent \[[@B3]\].

In the past decades, the emergence and spread of*Salmonella* multidrug resistant (MDR) strains have also contributed to increasing the impact that these pathogens have had in public health. The insurgence of MDR has generally been linked to acquisition of resistance genes located on plasmids, transposons, genomic islands, and integrons. For example, the multidrug resistance exhibited by the pandemic*S.* Typhimurium definitive phage type 104, (DT104), is due to resistance genes located within a chromosomal genomic island termed SGI1 composed of a 43 kbp region in which lies a 13 kbp gene cluster of*aadA2*,*floR*,*tet*(G), *bla* ~PSE-1~, and*sul1* encoding resistance for streptomycin, chloramphenicol, tetracycline, ampicillin, and sulfamethoxazole, respectively \[[@B4]\].

The constant increase of antimicrobial resistance is a global scale problem and it raises concern on the choice of antimicrobials available for the treatment of bacterial infections, particularly for those pathogens of major social relevance. It is thus necessary to implement measures that may contribute to better assessing the extent of resistance-gene diffusion among these pathogens. Both monitoring and characterisation of the antimicrobial susceptibility are undoubtedly valuable investigation systems that fulfill the purpose of such measures. Antimicrobial resistance is usually acquired by point mutations in the bacterial genome or by horizontal transfer of genetic elements harbouring resistance genes. Additionally, gene capture and expression elements called integrons have recently been shown to play an important role in acquisition and dissemination of resistance genes. Among the different classes of integrons, class 1 is the most detected and found strongly associated with capture of antimicrobial resistance genes. Class 1 integrons are then recognised as major contributors to the problem of multidrug-resistant pathogens \[[@B5]\]. In*S. enterica*, class 1 integrons are common and greatly contribute to the extent of antimicrobial resistance in this species \[[@B6]\].

If genetic characterization of antimicrobial resistances was combined with molecular strain typing, it would greatly benefit knowledge on the spread of resistance genes among the clonal groups of*Salmonella* strains principally identified in the clinical field. Phage typing and pulsed-field gel electrophoresis (PFGE) have become universally recognized as the reference methods for*Salmonella* strain subtyping.

In Italy, until 2006, the most common phage types identified among MDR clinical*S.* Typhimurium strains were DT104, U302, and DT7 \[[@B3]\]. The first was strongly associated with isolates pulsotype STYMXB.0061 resistant to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline, while strains U302 and DT7 were pulsotype STYMXB.0079 and resistant to ampicillin, streptomycin, sulfamethoxazole, and tetracycline. However, in Southern Italy (where*Salmonella* infections are endemic), data on resistance genes and clonal relationship among the MDR strains isolated from clinical cases is poor \[[@B7]\]. In this study, MDR*S.* Typhimurium strains isolated from several hospitals, from 2006 to 2008, were phage typed and characterised by pulsed field gel electrophoresis (PFGE). The genetic basis of the antimicrobial resistance was also established.

2. Materials and Methods {#sec2}
========================

2.1. Bacterial Isolates and Antimicrobial Susceptibility Testing {#sec2.1}
----------------------------------------------------------------

From January 2006 to December 2008, four hundred and seventy-seven*Salmonella* strains were isolated from clinical cases which occurred in Southern Italy. Two hundred and fifty-five were*S. enterica* serovar Typhimurium. Strains were isolated from six different hospitals scattered among the Italian neighbouring regions of Apulia and Basilicata. Biochemical identification of*Salmonella* was confirmed by an automated system (Microscan, dade Behring, Milan, Italy) and serotyping was performed by agglutination tests with specific antisera O and H antigens (Bio-Rad Laboratories, Italy). Classification was performed according to the Kauffmann-White scheme \[[@B8]\].

All isolates were included in the database of the Enter-net Surveillance Network at the Institute of Hygiene of the University of Bari (Italy) coordinated by the Istituto Superiore di Sanità, Rome (Italy). There were sixty-two bacteria that were resistant to at least one agent in three or more of the antimicrobial categories tested (namely, aminoglycosides, folate pathway inhibitors, penicillins, phenicols, and tetracyclines) and so defined as MDR \[[@B9]\].

Antimicrobial susceptibility testing was carried out by the agar disk diffusion test on Mueller-Hinton agar (Oxoid, Milan, Italy), following the Clinical and Laboratory Standards Institute (CLSI) guidelines \[[@B10]\]. The antimicrobial disks were ampicillin (A; 10 *μ*g), chloramphenicol (C; 30 *μ*g), kanamycin (K; 30 *μ*g), streptomycin (S; 10 *μ*g), sulfamethoxazole (Su; 25 *μ*g), tetracycline (T; 30 *μ*g), and trimethoprim (Tp 5 *μ*g).*E. coli* ATCC 25922 was used as a quality control strain.

2.2. PCR Detection of SGI, Class 1 Integrons, and Antimicrobial Resistance Genes {#sec2.2}
--------------------------------------------------------------------------------

Primers used to detect SGI1, class 1 integrons, and the antimicrobial resistance genes*aadA1, aadA2*, and*strAB* (encoding resistance for streptomycin; category aminoglycosides), *bla* ~PSE-1~ and *bla* ~TEM~ (encoding resistance for ampicillin; category penicillins),*floR* (encoding resistance for chloramphenicol; category phenicols),*sul1* and*sul2* (encoding resistance for sulfamethoxazole; category folate pathway inhibitors), and*tet*(B),*tet*(C), and*tet*(G) (encoding resistance for tetracycline; category tetracyclines) were as reported previously \[[@B11], [@B12]\]. Primers to detect the antimicrobial resistance genes *bla* ~OXA-30~ (encoding resistance for ampicillin),*catA1* (encoding resistance for chloramphenicol),*dfrA1* and*dfrA12* (encoding resistance for trimethoprim; category folate pathway inhibitors), and*tet*(A) and*tet*(D) (encoding resistance for tetracycline) were designated in this study. All primers are listed in [Table 1](#tab1){ref-type="table"}. The primers employed in the current study were based on sequences available in GenBank and designed by using the Primer3 (version 4.0.0) software (<http://primer3.wi.mit.edu>). Genomic DNA was extracted as previously described \[[@B13]\]. PCRs were performed in a total volume of 25 *μ*L containing 50 to 100 ng of total DNA, 1X PCR buffer (10 mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl~2~; pH8.3), 200 *μ*M of each deoxynucleoside triphosphate (dNTP), 20 *μ*M of each primer, and 1 U*Taq* polymerase (Takara Bio Inc., Otsu, Shiga, Japan).

Antimicrobial gene cassettes integrated into class 1 integrons were amplified with primers 5CS-F and 3CS-R and cloned into pGEM-T Easy vector (Promega, Milan, Italy) in accordance with the manufacturer\'s instructions.*E. coli* JM109 was used as a recipient strain. The cloned products were purified using the Pure Yield Plasmid Miniprep System (Promega) and sequenced by the Big Dye Terminator method (BMR Genomics, Padova, Italy). The resulting DNA sequences were analysed for similarity by using the BLAST program available on the NCBI BLAST homepage (<http://www.ncbi.nlm.nih.gov/BLAST>).

2.3. PFGE and Phage Typing {#sec2.3}
--------------------------

Genomic restriction was performed according to the standardized PulseNet*Salmonella* protocol \[[@B14]\]. Agarose-embedded DNA was digested with 40 U of*Xba*I for 3 h at 37°C. The restriction fragments were separated by electrophoresis in Tris-borate-EDTA (44.5 mM Tris-borate, 1 mM EDTA; pH 8.0) at 14°C for 20 h using a CHEF-DR III (Bio-Rad, Milan, Italy). Electrophoresis conditions were as follows: 6 V/cm, angle of 120°C, for 20 h with pulse times of 2.2 to 63.8 s. The*Salmonella* Braenderup H9812 strain was used as a molecular standard. The PFGE agarose gels were stained with ethidium bromide (40 *μ*g/mL) and the DNA band images were acquired by the Gel Doc-It photo documentation system (Gel Doc-It photo documentation system, UVP, Upland, CA, USA).

PFGE profiles in digital tagged image file format (TIFF files) were analyzed with the BioNumerics software package v.6.6 (Applied Maths, Sint-Martens-Latem, Belgium) \[[@B15]\]. DNA profiles differing in one or more DNA fragments were considered as distinct patterns. Strains with a coefficient of similarity ≥90% were classified as genetically closely related. All PFGE profiles were compared with those included in the PulseNet-Europe international database and named with a six letter code followed by a four digit numerical identifier, for example, STYMXB.0006. Dendrogram and cluster analysis were performed using algorithms available within the BioNumerics software package v.6.6 ([Figure 1](#fig1){ref-type="fig"}). Percent similarity between different chromosomal fingerprints was scored by the Dice coefficient. The unweighted pair group method with arithmetic means (UPGMA), with a 1.00% tolerance limit and 1.00% optimisation, was used to obtain the dendrogram. DNA profiles differing by one or more DNA fragments were considered as distinct patterns. Phage typing was performed according to the standard procedure \[[@B16]\].

3. Results {#sec3}
==========

3.1. Antimicrobial Susceptibility, Pulsotype, and Phage Typing {#sec3.1}
--------------------------------------------------------------

Six distinct resistance patterns were identified within the 62 MDR*S.* typhimurium strains analysed in this study ([Table 2](#tab2){ref-type="table"}). The resistance pattern to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim (termed resistance pattern ACSSuT) was that prevalent (83.9%), being identified in 52 strains. All others resistance patterns were identified either in single (ASSuT, ASSuTp, and AKSSuT) or in a low number of isolates (ASuTTp and ACSSuTTp).

Strains were characterised by genomic*Xba*I restriction patterns and resolved through a pulsed field gel electrophoresis and phage typing. PFGE profiles were compared with those included in the PulseNet-Europe international database and specific pulsotypes were assigned when the coefficient of similarity had a value ≥90%. Among the 52 strains with resistance pattern ACSSuT, 39 were pulsotype STYMXB.0061 with phage types distributed as follows: DT120 (84.6%), U302 (13.5%), and RDNC (1.9%). The remaining 13 strains with resistance pattern ACSSuT were pulsotypes STYMXB.0140 (4) or unnamed (9), and all of them were classified as phage type DT120. Five strains resistance pattern ASuTTp were pulsotype STYMXB.0113: two strains were classified DT35 and three DT193. Two isolates exhibiting the resistance pattern ACSSuTTp and the single isolates with resistance patterns ASSuT, ASSuTp, and AKSSuT were pulsotype unnamed and phage types DT120, DT7var, DT1, and U302, respectively.

3.2. Resistance Genes Associated with SGI1 {#sec3.2}
------------------------------------------

Identification of SGI1 and associated resistance genes was performed by PCR. Among the 52 strains with resistance pattern ACSSuT, 46 were positive for the presence of SGI1. Resistance genes (*aadA2*,*floR*,*tet*(G), *bla* ~PSE-1~, and*sul1*) usually harboured by SGI1 were identified and their genetic organization proved indistinguishable from that reported for SGI1 \[[@B4]\]. SGI1 and associated resistance genes were also identified in strains with resistance pattern ACSSuTTp and found identical to that identified in strains with resistance pattern ACSSuT. Strains with resistance patterns ASuTTp, AKSSuT, ASSuT, and ASSuTp were all negative for the presence of SGI1.

3.3. Resistance Genes and Class 1 Integrons {#sec3.3}
-------------------------------------------

Class 1 integrons were identified in all strains with resistance patterns ACSSuT and ACSSuTTp. Two amplicons of 1,009 bp and 1,197 bp were obtained among the 46 strains with resistance pattern ACSSuT and SGI1 positive. The nucleotide sequence of the gene cassettes was determined and two open reading frames (ORFs) of 852 and 987 bp were detected and found homologous to*aadA2* and *bla* ~PSE-1~, respectively. PCR analysis was further extended for detection of*sul1* and its linkage to class 1 integron. The*sul1* gene was found associated only with the class 1 integron harbouring the *bla* ~PSE-1~ gene cassette. These data further confirmed the presence of SGI1. An amplicon of 2,013 bp was obtained from the remaining 6 strains with resistance pattern ACSSuT (SGI1 negative). Two ORFs of 813 and 987 bp, organised as a gene cassette array, were identified and found homologous to *bla* ~OXA-30~ and*aadA1*. The presence of both *bla* ~OXA-30~ and*aadA1*, in these 6 isolates, was also confirmed by PCR and*sul1* was found associated with the gene cassette array. Detection of*catA1* and*tet*(B) completed the analysis of the resistance genes in these 6 isolates.

The strains with resistance pattern ACSSuTTp additional to SGI1, indistinguishable from that identified in strains with resistance pattern ACSSuT, harboured another class1 integron element. The gene cassette amplicon (1,534 bp) was sequenced and two ORFs of 474 and 789 bp were identified. The ORFs were found homologous to*dfrA1* and*aadA1*, respectively.

In strains with resistance pattern ASuTTp, the identified resistance genes were *bla* ~TEM~,*sul2*,*tet*(B), and*dfrA12*. In the single strains with resistance patterns AKSSuT, ASSuT, and ASSuTp, the resistance genes were *bla* ~TEM~,*sul2*,*strAB*,*tet*(B); *bla* ~TEM~,*sul2*,*strAB*,*tet*(A); and *bla* ~TEM~,*sul2*,*dfrA12*, respectively. The genetic basis for resistances to kanamycin (resistance pattern AKSSuT) and streptomycin (resistance pattern ASSuTp) was not identified.

4. Discussion {#sec4}
=============

*Salmonella* infections still remain a major public health concern in many countries with an estimated incidence of 15.1 cases per 100,000 persons in the United States and 42.2 cases per 100,000 persons in the EU \[[@B17]\]. In Italy, the average annual incidence is 14 cases per 100,000 persons \[[@B18]\]. However, since*Salmonella* infections are generally based on the identification of*Salmonella* strains from stool culture, data officially reported are likely to represent only a fraction of infections which really occur. The difference between reported cases and those probably occurring has recently been investigated by a study that assessed the seroincidence of*Salmonella* infections in eight European countries, Italy included \[[@B18]\]. The study demonstrated the misleading data on the incidence of*Salmonella* infections based only on numbers of stool culture-confirmed cases. Hence, the need to integrate epidemiological data with those gained by novel methods of investigation such as the assessment of cases by seroincidence.

*Salmonella* is also the leading cause of hospitalization from foodborne pathogens and the increase of antimicrobial resistance often represents a problem for the choice of a proper antimicrobial therapy (if required). A clear example is provided by the insurgence in the mid-1980s (in the United Kingdom) of the MDR*S.* Typhimurium phage type 104, resistance pattern ACSSuT encoded by SGI1, and its subsequent diffusion. Shortly after its emergence, detection of the MDR*S.* Typhimurium DT140 constantly increased among 29 countries which took part in a survey conducted from 1992 to 2001 \[[@B19]\]. In the following years, this clone became virtually pandemic.

In Italy, a survey conducted from 1992 to 2000 highlighted the presence of this pandemic clone from 1992 \[[@B20]\]. Detection of the MDR*S.* Typhimurium DT104, resistance pattern ACSSuT, remained constant from 2002 to 2004 accounting for 20% of the*S.* Typhimurium strains of clinical origin \[[@B21]\].

In this study, we report the characterisation of 62 MDR*S.* Typhimurium strains isolated from clinical cases which occurred in Southern Italy from 2004 to 2006. The incidence of*S.* Typhimurium was of 53.5% (255 strains out of the 477), data that confirmed the prevalent detection of this serovar in Italy. Multidrug resistance was detected in 24.3% of the*S.* Typhimurium strains. STYMXB.0061 was the prevalent (62.9%) identified pulsotype. This datum is in agreement with that reported by other studies STYMXB.0061 being one of the most common profiles identified in*S.* Typhimurium \[[@B22]\] and in Italy reported as the second PFGE profile detected in human isolates from 2003 to 2006 \[[@B23]\]. STYMXB.0061 is strongly associated with the phage type 104 and this relationship is documented by a number of studies on*S.* Typhimurium strains isolated from both human and animal sources \[[@B12], [@B22], [@B23]\]. SGI1, first detected in*S.* Typhimurium strains phage type 104, has also been identified in strains with phage types related to DT104 such as DT120, U302, or DT12 \[[@B24]\]. Strains DT120 or DT12 with resistance pattern ACSSuT exhibited PFGE profiles identical to those shown by isolates DT104 with resistance pattern ACSSuT and distinct from profiles exhibited by strains of the same phage types \[[@B25]\]. Such a feature has been supposed due to a change in phage susceptibility in a small proportion of*S.* Typhimurium strains phage type 104 with resistance pattern ACSSuT rather than to horizontal gene transfer of resistance determinants. Additionally, phage typing has widely been used for strain characterisation, and in surveillance and outbreaks investigation \[[@B26]\]. Interestingly, in our survey, none of the isolates STYMXB.0061 with resistance pattern ACSSuT was DT104. Thirty-one (79.5%) were phage type DT120 and seven (15.2%) phage type U302. The prevalent identification of phage type DT120 would suggest, at least in Southern Italy, a phage type shifting of the*S.* Typhimurium strain DT104 (resistance pattern ACSSuT, pulsotype STYMXB.0061) of clinical origin. This possibility is also supported by the virtual absence of phage type DT120 detection in*S.* Typhimurium strains of human and non-human sources isolated in Italy at least until 2000 \[[@B27], [@B28]\]. In a subsequent study performed in Italy (2002--2004) on*S.* Typhimurium strains isolated from human and animal sources, DT120 was rarely detected among the 367 identified MDR strains (resistance pattern ACSSuT). Only 7 isolates were DT120 while 196 (72.3%) were DT104. Additionally, for all of these 7 strains, neither source of isolation nor antimicrobial resistance genes were specified \[[@B3]\].

MDR*S.* Typhimurium DT120 strains (e.g. resistant to ASSuT, encoded by *bla* ~TEM~,*strAB*,*sul2* and*tet*(B)) have recently emerged in European countries, with pigs being the likely reservoir of infection \[[@B29]\]. Indeed, in a survey on the prevalence of*Salmonella* in slaughtered pigs, conducted in the EU from 2006 to 2007, the serovars Typhimurium and Derby were those most frequently identified \[[@B30]\].

The potential impact of*S.* Typhimurium DT120 in public health has recently been highlighted by clinical outbreaks which occurred in Denmark in 2008 and the UK in 2011. Infections linked to the consumption of pork or pork products \[[@B31]--[@B34]\]. Moreover, in Greece, DT120 is associated with the most frequently occurring clones in human and pigs (2006--2011) \[[@B33]\]. However, none of these DT120 isolates was STYMXB.0061 (STYMXB.0083 was the pulsotype detected from the outbreak in UK, while STYMXB.0010 was that identified in Denmark and Greece) and, above all, the antimicrobial resistance patterns (mainly ASSuT and ACSSuTTp) were not linked to the presence of SGI1.

In Italy, the phage type DT120 has commonly been detected from finishing pigs in slaughterhouses \[[@B35]\]. However, these data come from slaughterhouses located in Northern Italy while data from Southern Italy, to the best of our knowledge, are still unavailable. Additionally, none of the*S.* Typhimurium DT120 strains isolated from slaughterhouses in Northern Italy was resistance pattern ACSSuT and no data was available on their pulsotype. It would be interesting to investigate the molecular and phenotypic features of*S.* Typhimurium strains isolated from swine samples in Southern Italy. This might help determine possible epidemiological routes that have contributed to the spread of*S.* Typhimurium strains phage type DT120 that we detected from the clinical isolates.

The integrons*dfrA1*-*aadA1* and *bla* ~OXA-30~-*aadA1* have been identified in*S.* Typhimurium strains isolated from different geographic areas \[[@B6]\]. The identification of distinct groups of integrons together with phage typing and molecular strain characterisation represents valuable markers to assess possible clonal expansion. Interestingly, the above types of integrons were all identified in MDR strains DT120 with different pulsotype (STYMXB.0113 or Unnamed) highlighting the presence of distinct DT120 clones among clinical cases in Southern Italy.

5. Conclusions {#sec5}
==============

In this study, we first described the extent of the antimicrobial resistance genes and associated genetic elements among clinical MDR*S.* Typhimurium strains isolated from an Italian area where Salmonella infections are endemic. Data presented suggest, in this endemic area, a phage type shifting of the pandemic clone DT104 (resistance pattern ACSSuT) to DT120. Such a shifting, to the best of our knowledge, has occurred recently since no clinical*S.* Typhimurium strains DT120 (resistance pattern ACSSuT encoded by SGI encoded) was not reported until 2004. The extent and persistence of these findings raise concerns in public health about the possible diffusion of these emerging DT120 clones.
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###### 

Primers used for PCR amplification of resistance genes.

  Primer       5′-3′ sequence                 Gene target             Amplicon size (bp)   TA     Reference
  ------------ ------------------------------ ----------------------- -------------------- ------ ------------
  aadA1-F      TTTGATCAACGACCTTTTGGAAAC       *aadA1*and *aadA2*      294                  58°C   \[[@B11]\]
  aadA-R       GGACAACGTAAGCACTACATTTCG                                                           
                                                                                                  
  blaoxa30-F   ATTATCTACAGCAGCGCCAGTGCATC     *bla* ~OXA-30~          716                  63°C   This study
  blaoxa30-R   TTCGACCCCAAGTTTCCTGTAAGTGC                                                         
                                                                                                  
  blaPSE-1-F   GGATTACAATGGCAATCAGCGCTTCC     *bla* ~PSE-1~           658                  65°C   \[[@B12]\]
  blaPSE-1-R   AATCGCATCATTTCGCTCTGCCATTG                                                         
                                                                                                  
  blaTEM1-F    TGAAGATCAGTTGGGTGCACGAGTGG     *bla* ~TEM-1~           700                  63°C   \[[@B11]\]
  blaTEM1-R    AGTTGCCTGACTCCCCGTCGTGTAGA                                                         
                                                                                                  
  catA1-F      CACCGTTGATATATCCCAATGGCATCGT   *catA1*                 582                  62°C   This study
  catA1-R      CTGCCGACATGGAAGCCATCACAAAC                                                         
                                                                                                  
  dfrA1-F      TATTCCATGGAGTGCCAAAGGTGAAC     *dfrA1*                 375                  63°C   This study
  dfrA1-R      GAGGCGAAGTCTTGGGTAAAAACTGG                                                         
                                                                                                  
  dfrA12-F     CAGTACGCATTTATCTCGTTGCTGCG     *dfrA12*                417                  63°C   This study
  dfrA12-R     CAAGCTCGAATTCTGTTTCGTTGAGC                                                         
                                                                                                  
  floR-F       CTCCTTTCGACATCCTCGCTTCACTG     *floR*                  636                  64°C   \[[@B12]\]
  floR-R       AGAAGACGAAGAAGGTGCCCATACCG                                                         
                                                                                                  
  sul1-F       TCGGCATTCTGAATCTCACCGAGGAC     *sul1*                  786                  64°C   \[[@B12]\]
  sul1-R       AAATTTCGCGAGGGTTTCCGAGAAGG                                                         
                                                                                                  
  sul2-F       GACAGTTTCTCCGATGGAGGCCGGTA     *sul2*                  700                  64°C   \[[@B12]\]
  sul2-R       GTGTGCGGATGAAGTCAGCTCCACCT                                                         
                                                                                                  
  strA-F       TGGTTGCCTGTCAGAGGCGGAGAATC     *strAB*                 1466                 63°C   \[[@B11]\]
  strB-R       ATCGACGTCCAGCGCACGAGAGAATG                                                         
                                                                                                  
  tetA-F       CCTGATCGTAATTCTGAGCACTGTCG     *tet*(A)                1089                 63°C   This study
  tetA-R       CACCCGTTCCACGTTGTTATAGAAGC                                                         
                                                                                                  
  tetB-F       CAGGTTATCTTTGCTCCTTGGCTTGG     *tet*(B)                1014                 63°C   \[[@B11]\]
  tetB-R       TTGAGGGGTTAACATGAAGGTCATCG                                                         
                                                                                                  
  tetC-F       GGATATCGTCCATTCCGACAGCATCG     *tet*(C)                745                  63°C   \[[@B11]\]
  tetC-R       GATAATGGCCTGCTTCTCGCCGAAAC                                                         
                                                                                                  
  tetD-F       ACTGTCCAATGTGCTGTGGATGTTGT     *tet(D)*                747                  63°C   This study
  tetD-R       CTGACCAGCACACCCTGTAGTTTTCC                                                         
                                                                                                  
  tetG-F       GAGCCGCAGTCGATTACACGATTATG     *tet*(G)                680                  64°C   \[[@B12]\]
  tetG-R       CAACAGAATCGGGAACACCATCCATC                                                         
                                                                                                  
  intI1-F      CGAACCGAACAGGCTTATGTCCACTG     *intI1*                 838                  63°C   \[[@B12]\]
  intI1-R      CATCGTCGTAGAGACGTCGGAATGG                                                          
                                                                                                  
  5CS-F        GCCTCGGGCATCCAAGCAGCAAGC       5′CS *attI*1 end 3′CS   variable             65°C   This study
  3CS-R        CTTGACCTGATAGTTTGGCTGTGAGCAA                                                       
                                                                                                  
  U7-L12       ACACCTTGAGCAGGGCAAAG           *tdhF*                  500                  60°C   \[[@B4]\]
  LJ-R1        AGTTCTAAAGGTTCGTAGTCG          *int*                                               
                                                                                                  
  104-RJ       TGACGAGCTGAAGCGAATTG           S044                    515                  60°C   \[[@B4]\]
  C9-L         AGCAAGTGTGCGTAATTTGG           *int2*                                              

###### 

Antimicrobial susceptibility, phage types, pulsotypes, PCR detection of SGI1, class 1 integrons, and resistance genes in *S*. Typhimurium strains isolated in Southern Italy in 2006--2008.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  PulseNet Europe\   Phage type\           Year\                           Resistance\        Class 1\                                                               SGI1   
  nomenclature       (no. of strains)      (no. of strains)                pattern^a^         integrons                                                                     
  ------------------ --------------------- ------------------------------- ------------- ---- ------------------------------ --------------------------------------- ------ ----
  STYMXB.0061        DT120 (31)            2006 (9); 2007 (13); 2008 (9)   ACSSuT        \+   *aadA2; bla* ~PSE-1~           *floR; sul1; tet(G)*                    \+     \+

  U302 (7)           2006 (1); 2008 (4)\   ′′                              \+            ′′   ′′                             \+                                      \+     
                     2008 (2)                                                                                                                                               

  ′′                 \+                    ′′                              ′′            \+   −                                                                             

  RDNC (1)           2006 (1)              ′′                              \+            ′′   ′′                             \+                                      \+     

                                                                                                                                                                            

  STYMXB.0113        ST193 (3)             2006                            ASuTTp        −    −                              *bla* ~TEM~ *; sul2; tet(A); dfrA12*    −      −

  DT35 (2)^b^        ′′                    ′′                              −             −    *bla* ~TEM~ *; sul2; tet(A)*   −                                       −      

                                                                                                                                                                            

  STYMXB.0140        DT120 (4)             2007 (4)                        ACSSuT        \+   *bla* ~OXA-30~-*aadA1*         *catA1*; *sul1*; *tet(B)*               −      −

                                                                                                                                                                            

  Unnamed 1          DT120 (9)             2006 (2); 2007 (3)              ACSSuT        \+   *aadA2*;*bla* ~PSE-1~          *floR*; *sul1*; *tet(G)*                \+     \+

  Unnamed 2          ′′                    2008 (2)                        ′′            \+   ′′                             ′′                                      \+     \+

  Unnamed 3          ′′                    2008 (2)                        ′′            \+   *bla* ~OXA-30~-*aadA1*         *catA1*; *sul1*; *tet(B)*               −      −

  Unnamed 4          ′′                    2007 (2)                        ACSSuTTp      \+   *aadA2; bla* ~PSE-1~ \         *floR*; *sul1*; *tet(G)*                \+     \+
                                                                                              *dfrA1*-*aadA1*                                                               

  Unnamed 5          DT7var^c^             2007 (1)                        AKSSuT        −    −                              *bla* ~TEM~;*sul2*;*strAB*;*tet(B)*     −      −

  Unnamed 6          DT1                   2008 (1)                        ASSuT         −    −                              *bla* ~TEM~;*sul2*; *strAB*; *tet(A)*   −      −

  Unnamed 7          U302^d^               2008 (1)                        ASSuTp        −    −                              *bla* ~TEM~;*sul2*; *dfrA12*            −      −
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^A, ampicillin; C, chloramphenicol; K, kanamycin; S streptomycin; Su, sulfamethoxazole; T, tetracycline; and Tp, trimethoprim.

^b^The resistance to Tp was not identified.

^c^The resistance to K was not identified.

^d^The resistance to S and Tp was not identified.

RDNC: the reaction pattern is not conforming to a recognised phage type.

Key: +, positive; −, negative.

[^1]: Academic Editor: Gundlapally S. Reddy
